Alleviation of Side Effects and Distress in Breast Cancer Patients by Cognitive-Behavioral Interventions: A Systematic Review and Meta-analysis

Journal of Clinical Psychology in Medical Settings
Oana Cobeanu, Daniel David

Abstract

Cognitive and behavioral interventions (CBI) have been used for breast cancer patients with various stages of the disease or undergoing different treatments. However, no quantitative review has summarized their efficacy on the side effects of treatment, distress, and quality of life in the acute treatment setting after diagnosis. This meta-analysis synthesizes data from 19 randomized clinical trials in order to: (a) provide an estimation of overall effect of CBI in breast cancer patients during treatment for breast cancer, i.e., neo-adjuvant and adjuvant treatment; (b) provide average effect sizes on side effects of treatment, distress, and quality of life; and (c) test possible moderators of effect size. The results show that CBI yielded a small effect size overall, specifically on general side effects of treatment, nausea, vomiting, distress, and quality of life. Individual and behavioral interventions seem to elicit better results on distress and on general side effects of treatment, respectively. While more studies are needed with regard to specific side effects (i.e., fatigue, pain, and sleep disturbance), the overall results clearly support the use of CBI in breast cancer patients during treatment.

References

Aug 1, 1988·The Journal of Hospital Infection·J Cohen
Nov 5, 1988·BMJ : British Medical Journal·L R BridgeR G Priest
May 1, 1985·Journal of Personality and Social Psychology·E DienerR A Emmons
May 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H SchipperM Levitt
Dec 1, 1983·Journal of Health and Social Behavior·S CohenR Mermelstein
Oct 1, 1996·Journal of Pain and Symptom Management·N SamarelJ Fawcett
Aug 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G MarchioroO Vinante
Jun 13, 1998·Psychosomatic Medicine·P B JacobsenK K Fields
Apr 10, 1999·Archives of General Psychiatry·V S HelgesonJ Yasko
Mar 1, 1992·Journal of Sleep Research·A W MacLeanJ B Knowles
Nov 10, 2000·Lancet·M ColleoniA Goldhirsch
Mar 29, 2001·Irish Journal of Medical Science·C BlakeY M O'Meara
Apr 12, 2001·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D M HannF Baker
Jun 8, 2001·Journal of the National Cancer Institute·W H ReddK N DuHamel
Mar 7, 2002·Critical Reviews in Oncology/hematology·Barbara Alicja Jereczek-FossaRoberto Orecchia
Mar 21, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alexander MolassiotisT S K Mok
May 7, 2002·BMJ : British Medical Journal·H Gilbert Welch, Juliana Mogielnicki
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Oct 1, 1964·Journal of Consulting Psychology·M ZUCKERMANE VALERIUS
Jul 22, 2004·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Guy H Montgomery, Dana H Bovbjerg
Feb 8, 2005·BMJ : British Medical Journal·Caroline BurgessAmanda Ramirez
Apr 7, 2005·Journal of the National Cancer Institute·Julia BohliusAndreas Engert
Apr 28, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hee J YooOh S Han
Jan 10, 2006·Journal of Behavioral Medicine·Kristin Tatrow, Guy H Montgomery
May 2, 2007·Psychological Bulletin·James C CoyneSteven C Palmer
Oct 12, 2007·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Heather S JimPaul B Jacobsen
Nov 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles W GivenDavid Decker
Dec 19, 2008·Psycho-oncology·Ann M BergerSusanna G Von Essen
Jan 27, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·J Yarnold

❮ Previous
Next ❯

Citations

Oct 21, 2019·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Marit L Bovbjerg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.